354
Participants
Start Date
November 20, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
June 30, 2026
XTR006
all patients will receive one injection of \[18F\]XTR006, a PET radiopharmaceutical selective for NFTs. For the injection, subjects will receive a target dose of 4-6 mCi IV as a bolus injection. \[18F\]XTR006 injection will be followed by a 10 ml saline flush.
RECRUITING
Chinese PLA General Hospital, Beijing
Sinotau Pharmaceutical Group
INDUSTRY